SFX by Ex Libris Inc.

Title:	Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk
Source:	Nature Genetics [1061-4036] Broderick, Peter yr:2011

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Weinhold, N. "The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma." Nature Genetics 45.5 (2013): 522-525.
description	2.	Chubb, D. "Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk." Nature Genetics 45.10 (2013): 1221-1225.
description	3.	Sebat, J. "Large-Scale Copy Number Polymorphism in the Human Genome." Science 305.5683 (2004): 525-8.
description	4.	Zwick, C. "Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MM.(Report)." International journal of cancer 135.4 (2014): 934-.
description	5.	Morgan, G J. "Inherited genetic susceptibility to multiple myeloma." Leukemia 28.3 (2013): 518-524.
description	6.	Iafrate, A John J. "Detection of large-scale variation in the human genome." Nature genetics 36.9 (2004): 949-51.
description	7.	Tuzun, E. "Fine-scale structural variation of the human genome." Nature genetics 37.7 (2005): 727-32.
description	8.	Aburatani, R. "Global variation in copy number in the human genome." Nature 444.7118 (2006): 444-54.
description	9.	Wild, Richard S. "A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia." Nature Genetics 40.10 (2008): 1204-10.
description	10.	Ziv, E. "Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients." Nature Communications 6 (2015): 7539-.
description	11.	FAIMAN, B. "Myeloma Genetics and Genomics: Practice Implications and Future Directions." Clinical lymphoma, myeloma and leukemia 14.6 (2014): 436-440.
description	12.	Baker, A. "Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach." Blood 121.16 (2013): 3147-3152.
description	13.	Thomas, E.E. E. "Distribution of short paired duplications in mammalian genomes." Proceedings of the National Academy of Sciences of the United States of America 101.28 (2004): 10349-54.
description	14.	Sharp, Andrew J J. "Segmental duplications and copy-number variation in the human genome." American journal of human genetics 77.1: 78-88.
description	15.	Perkins, N. "Emerging from NF-κB’s Shadow, SUMOylated IκBα Represses Transcription." Cancer cell 24.2 (2013): 139-140.
description	16.	Kachuri, L. "Multiple pesticide exposures and the risk of multiple myeloma in Canadian men." International journal of cancer 133.8 (2013): 1846-1858.
description	17.	Canzian, F. "Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium." British journal of haematology 157.3 (2012): 331-338.
description	18.	Weinhold, N. "Inherited genetic susceptibility to monoclonal gammopathy of unknown significance." Blood 123.16 (2014): 2513-7.
description	19.	Kharfan Dabaja, L J N A. "Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors." Leukemia 28.3 (2013): 507-517.
description	20.	Hofmann, Jonathan N. "Body Mass Index and Physical Activity at Different Ages and Risk of Multiple Myeloma in the NIH-AARP Diet and Health Study." American journal of epidemiology 177.8 (2013): 776-786.